Kamran Ahrar, MD, MBA

University of Texas M. D. Anderson Cancer Center, United States

Kamran Ahrar, MD, MBA is a Professor in The Department of Interventional Radiology at the University of Texas MD Anderson Cancer Center (MDACC) in Houston, Texas. Shortly after he joined MD Anderson he established a minimally invasive percutaneous tumor ablation program. Today, percutaneous ablation, with or withouth tumor embolization, is a thriving program providing minimally invasive treatment options to many patients with liver, kidney, lung and bone tumors.

Dr. Ahrar has authored or co-authored over 80 peer reviewed articles in nationally recognized journals and 19 book chapters. He is board certified in Diagnostic Radiology with a subspecialty in Interventional Radiology. He speaks regularly at national and international conferences and symposiums. Dr. Ahrar is a member of the American College of Radiology, Soceity of Interventional Radiology, American College of Healthcare Exectuives just to name a few.

Presentation(s):

• Session VIII: HCC

  Saturday, September 5, 2020
  7:00 PM – 8:30 PM CDT

• Session 08: Renal Intervention

  ON-DEMAND

• Case 2: Ablation of T1a Renal Tumors: Technique and Outcomes

  ON-DEMAND

• Ablation for Colorectal Liver Metastases: What is the Evidence?

  ON-DEMAND

• Is SBRT Competing With Your Ablation Program for CRC Liver Metastases?

  ON-DEMAND

• Is First-line Y90 Dead, or What Do We Need to Design a Positive Study?

  ON-DEMAND

• Why is DEBIRI Not as Utilized as Y90, and Why Has No One Confirmed Fiorentini's Ph2 Results?

  ON-DEMAND

• What Adjunctive Procedures Do People Use to Boost Hypertrophy?

  ON-DEMAND

• In the Era of PRRT, Which Patients Should We Still Advocate for Locoregional Therapy?

  ON-DEMAND

• How Can We Make This Technology Accessible?

  ON-DEMAND